Ivan Bunganič, Daniela Ohlasová
Diagnostics and treatment of Helicobacter pylori (Hp) is a medical and economical problem as well. Rising resistance of bacteria towards macrolids and metronidazol, lately also to chinolons (Levofloxacin), together with a growth of costs needed for diagnostics or newly introduced medicaments, force us to look for the rational approach to Hp treatment that have to comply with European and national guidelines. Work on new technical directions from the workshop of Healthcare Ministry of the Slovak Republic, general expert for gastroenterology, and the working group for Hp at the SGS, has taken more than one year time. These revised and filled in guidelines for Hp diagnostics and treatment proved the necessity of cooperation among medical departments and branches.